References
- 1. Dirix P, Nuyts S, Vander Poorten V, Delaere P, Van den Bogaert W. The influence of xerostomia after radiotherapy on quality of life: results of questionnaire in head and neck cancer. Support Care Cancer. 2008; 16:171-9.10.1007/s00520-007-0300-5
- 2. Guchelaar HJ, Vermes A, Meerwaldt JH. Radiationinduced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer. 1997; 5:281-8.10.1007/s005200050075
- 3. Dirix P, Nuyts S, Vander Poorten V, Dalaere P, Van den Bogaert W. Efficacy of the Bioxtra dry mouth care system in the treatment of radiotherapy-induced xerostomia. Support Care Cancer. 2007; 15:1429-36.10.1007/s00520-006-0210-y
- 4. Ship JA, Hu K. Radiotherapy-Induced salivary dysfunction. Semin Oncol. 2004; 31 (6suppl 18):29-36.10.1053/j.seminoncol.2004.12.009
- 5. Hahnel S, Behr M, Handel G, B⃞rgers R. Saliva substitutes for the treatment of radiation-induced xerostomia-a review. Support Care Cancer. 2009; 17: 1331-43.10.1007/s00520-009-0671-x
- 6. Epstein JB, Emerton S, Le ND, Stevenson-Moore P. A double-blind crossover trial of Oral Balance gel and BioteneR toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol. 1999; 35:132-7.10.1016/S1368-8375(98)00109-2
- 7. Momm F, Volegova-Neher NJ, Schulte-M⃞nting J, Guttenberger R. Different saliva substitutes for treatment of xerostomia following radiotherapy: a prospective crossover study. Strahlenther Onkol. 2005; 181:231-6.10.1007/s00066-005-1333-7
- 8. Oh DJ, Lee JY, Kim YK, Kho HS. Effects of carboxymethylcellulose (CMC)-based artificial saliva in patients with xerostomia. Int. J Oral Maxillofac Surg. 2008; 37:1027-31.
- 9. Visch LL, Gravenmade EJ, Schaub RM, Van Putten WL, Vissink A. A double-blind crossover trial of CMC and mucin-containing saliva substitutes. Int J Oral Maxillofac Surg. 1986; 15:395-400.
- 10. Vissink A, s-Gravenmade EJ, Panders AK, Vermey A, Petersen JK, Visch LL, et al. A clinical comparison between commercially available mucin- and CMCcontaining saliva substitutes. Int J oral Surg. 1983; 12: 232-8.10.1016/S0300-9785(83)80048-9
- 11. Davies AN. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med. 2000; 14: 197-203.10.1191/026921600672294077
- 12. Boonroung T, Narongdej T, Vadcharavivad S. A comparative study of carboxymethylcellulose and enzyme-containing saliva substitute effects on quality of life in head and neck cancer patients with selfreported post-radiation-xerostomia. Thai Pharm and Health Science J. 2011; 6:17-24.
- 13. Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006; 66:445-53.10.1016/j.ijrobp.2006.05.002
- 14. Shahdad SA, Taylor C, Barclay SC, Steen IN, Preshaw PM. A double-blind cross-over study of Biotene Oralbalance and Bioxtra systems as salivary substitutes in patients with post-radiotherapy xerostomia. Eur J Cancer Care (Engl). 2005; 14: 319-26.10.1111/j.1365-2354.2005.00587.x
- 15. Henson BS, Inglehart MR, Eisbruch A, Ship JA. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol. 2001; 37:84-93.10.1016/S1368-8375(00)00063-4
- 16. Warde P, Kroll B, O’Sullivan B, Aslanidis J, Tew-George E, Waldron J, et al. A phase II study of Biotene in the treatment of post-radiation xerostomia in patients with head and neck cancer. Support Care Cancer. 2000; 8:203-8.10.1007/s005200050286
- 17. Brosky ME. The role of saliva in oral health: strategies for prevention and management of xerostomia. J Support Oncol. 2007; 5:215-25.
- 18. Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, Terrel JE, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-andneck cancer: initial report. Int J Radiat Oncol Biol Phys. 2005; 63:725-31.10.1016/j.ijrobp.2005.02.045
- 19. Dirix P, Nuyts S, Van den Bogaert W. Radiationinduced xerostomia in patients with head and neck cancer:a literature review. Cancer. 2006; 107:2525-34.10.1002/cncr.22302
- 20. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003; 57:61-70.10.1016/S0360-3016(03)00361-4
- 21. Ruo Reddar MG, Allis S. Radiotherapy-induced taste impairment. Cancer Treat Rev. 2006; 32:541-7.10.1016/j.ctrv.2006.06.003
- 22. Temmel AF, Quint C, Schickinger-Fischer B, Hummel T. Taste function in xerostomia before and after treatment with saliva substitute containing carboxymethylcellulose. J. Otolaryngol. 2005; 34: 116-20.10.2310/7070.2005.04008
- 23. Hahnel S, Rosentritt M, Handel G, B⃞rgers R. Influence of saliva substitute films on initial Streptococcus mutans adhesion to enamel and dental substrata. J Dent. 2008; 36:977-83.10.1016/j.jdent.2008.08.004
- 24. Regelink G, Vissink A, Reintsema H, Nauta JM. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiationinduced xerostomia. Quintessence Int. 1998; 29: 383-8.
- 25. Silvestre FJ, Minguez MP, Su⃞e-Negre JM. Clinical evaluation of a new artificial saliva in spray form for patients with dry mouth. Med Oral Pathol Oral Cir Bucal. 2009; 14:E8-11